We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.
Gene namei
Official gene symbol, which is typically a short form of the gene name, according to HGNC.
Cancer-related genes Disease related genes Enzymes FDA approved drug targets Human disease related genes Metabolic proteins Plasma proteins
Predicted locationi
All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.
Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.
Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).
The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.
Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.
Chromosome
7
Cytoband
q36.1
Chromosome location (bp)
148807383 - 148884321
Number of transcriptsi
Number of protein-coding transcripts from the gene as defined by Ensembl.
The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).
In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl
The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.
At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.
Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).
The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).
If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.
Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
EZH2-201
EZH2-202
EZH2-203
EZH2-205
EZH2-206
EZH2-208
PROTEIN INFORMATIONi
The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.
The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.
The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.
The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Enzymes ENZYME proteins Transferases Metabolic proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Missense Mutations Disease related genes FDA approved drug targets Small molecule drugs Human disease related genes Cancers Cancers of haematopoietic and lymphoid tissues Congenital malformations Other congenital malformations Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II] GO:0000781 [chromosome, telomeric region] GO:0000785 [chromatin] GO:0000976 [transcription regulatory region sequence-specific DNA binding] GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding] GO:0000979 [RNA polymerase II core promoter sequence-specific DNA binding] GO:0001226 [RNA polymerase II transcription corepressor binding] GO:0001932 [regulation of protein phosphorylation] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0003714 [transcription corepressor activity] GO:0003723 [RNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005677 [chromatin silencing complex] GO:0005737 [cytoplasm] GO:0006306 [DNA methylation] GO:0006325 [chromatin organization] GO:0006348 [chromatin silencing at telomere] GO:0006355 [regulation of transcription, DNA-templated] GO:0006357 [regulation of transcription by RNA polymerase II] GO:0008168 [methyltransferase activity] GO:0008284 [positive regulation of cell population proliferation] GO:0010468 [regulation of gene expression] GO:0010629 [negative regulation of gene expression] GO:0010718 [positive regulation of epithelial to mesenchymal transition] GO:0014013 [regulation of gliogenesis] GO:0014834 [skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration] GO:0014898 [cardiac muscle hypertrophy in response to stress] GO:0016279 [protein-lysine N-methyltransferase activity] GO:0016571 [histone methylation] GO:0016740 [transferase activity] GO:0018024 [histone-lysine N-methyltransferase activity] GO:0021695 [cerebellar cortex development] GO:0021766 [hippocampus development] GO:0030183 [B cell differentiation] GO:0031490 [chromatin DNA binding] GO:0032259 [methylation] GO:0032355 [response to estradiol] GO:0034244 [negative regulation of transcription elongation from RNA polymerase II promoter] GO:0035098 [ESC/E(Z) complex] GO:0035984 [cellular response to trichostatin A] GO:0036333 [hepatocyte homeostasis] GO:0042054 [histone methyltransferase activity] GO:0042127 [regulation of cell population proliferation] GO:0042752 [regulation of circadian rhythm] GO:0043021 [ribonucleoprotein complex binding] GO:0043406 [positive regulation of MAP kinase activity] GO:0043433 [negative regulation of DNA-binding transcription factor activity] GO:0043547 [positive regulation of GTPase activity] GO:0043565 [sequence-specific DNA binding] GO:0045120 [pronucleus] GO:0045605 [negative regulation of epidermal cell differentiation] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0046976 [histone methyltransferase activity (H3-K27 specific)] GO:0048387 [negative regulation of retinoic acid receptor signaling pathway] GO:0048468 [cell development] GO:0048511 [rhythmic process] GO:0050767 [regulation of neurogenesis] GO:0051154 [negative regulation of striated muscle cell differentiation] GO:0070301 [cellular response to hydrogen peroxide] GO:0070314 [G1 to G0 transition] GO:0070317 [negative regulation of G0 to G1 transition] GO:0070734 [histone H3-K27 methylation] GO:0070878 [primary miRNA binding] GO:0071168 [protein localization to chromatin] GO:0071902 [positive regulation of protein serine/threonine kinase activity] GO:0097421 [liver regeneration] GO:0098532 [histone H3-K27 trimethylation] GO:1900006 [positive regulation of dendrite development] GO:1902808 [positive regulation of cell cycle G1/S phase transition] GO:1904772 [response to tetrachloromethane] GO:1990841 [promoter-specific chromatin binding] GO:2000134 [negative regulation of G1/S transition of mitotic cell cycle]
Enzymes ENZYME proteins Transferases Metabolic proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Missense Mutations Disease related genes FDA approved drug targets Small molecule drugs Human disease related genes Cancers Cancers of haematopoietic and lymphoid tissues Congenital malformations Other congenital malformations Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II] GO:0000781 [chromosome, telomeric region] GO:0000785 [chromatin] GO:0001226 [RNA polymerase II transcription corepressor binding] GO:0003682 [chromatin binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006325 [chromatin organization] GO:0006348 [chromatin silencing at telomere] GO:0006355 [regulation of transcription, DNA-templated] GO:0008168 [methyltransferase activity] GO:0008284 [positive regulation of cell population proliferation] GO:0010718 [positive regulation of epithelial to mesenchymal transition] GO:0016279 [protein-lysine N-methyltransferase activity] GO:0016571 [histone methylation] GO:0016740 [transferase activity] GO:0018024 [histone-lysine N-methyltransferase activity] GO:0031490 [chromatin DNA binding] GO:0032259 [methylation] GO:0034968 [histone lysine methylation] GO:0035098 [ESC/E(Z) complex] GO:0042054 [histone methyltransferase activity] GO:0042752 [regulation of circadian rhythm] GO:0043406 [positive regulation of MAP kinase activity] GO:0043547 [positive regulation of GTPase activity] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0046976 [histone methyltransferase activity (H3-K27 specific)] GO:0048387 [negative regulation of retinoic acid receptor signaling pathway] GO:0048511 [rhythmic process] GO:0070317 [negative regulation of G0 to G1 transition] GO:0070734 [histone H3-K27 methylation] GO:0071902 [positive regulation of protein serine/threonine kinase activity] GO:1902808 [positive regulation of cell cycle G1/S phase transition] GO:1990841 [promoter-specific chromatin binding]
Enzymes ENZYME proteins Transferases Metabolic proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Missense Mutations Disease related genes FDA approved drug targets Small molecule drugs Human disease related genes Cancers Cancers of haematopoietic and lymphoid tissues Congenital malformations Other congenital malformations Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II] GO:0000781 [chromosome, telomeric region] GO:0000785 [chromatin] GO:0001226 [RNA polymerase II transcription corepressor binding] GO:0003682 [chromatin binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006325 [chromatin organization] GO:0006348 [chromatin silencing at telomere] GO:0006355 [regulation of transcription, DNA-templated] GO:0008168 [methyltransferase activity] GO:0008284 [positive regulation of cell population proliferation] GO:0010718 [positive regulation of epithelial to mesenchymal transition] GO:0016279 [protein-lysine N-methyltransferase activity] GO:0016571 [histone methylation] GO:0016740 [transferase activity] GO:0018024 [histone-lysine N-methyltransferase activity] GO:0031490 [chromatin DNA binding] GO:0032259 [methylation] GO:0035098 [ESC/E(Z) complex] GO:0042054 [histone methyltransferase activity] GO:0042752 [regulation of circadian rhythm] GO:0043406 [positive regulation of MAP kinase activity] GO:0043547 [positive regulation of GTPase activity] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0046976 [histone methyltransferase activity (H3-K27 specific)] GO:0048387 [negative regulation of retinoic acid receptor signaling pathway] GO:0048511 [rhythmic process] GO:0070317 [negative regulation of G0 to G1 transition] GO:0070734 [histone H3-K27 methylation] GO:0071902 [positive regulation of protein serine/threonine kinase activity] GO:1902808 [positive regulation of cell cycle G1/S phase transition] GO:1990841 [promoter-specific chromatin binding]
Enzymes ENZYME proteins Transferases Metabolic proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Missense Mutations Disease related genes FDA approved drug targets Small molecule drugs Human disease related genes Cancers Cancers of haematopoietic and lymphoid tissues Congenital malformations Other congenital malformations Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II] GO:0000781 [chromosome, telomeric region] GO:0000785 [chromatin] GO:0001226 [RNA polymerase II transcription corepressor binding] GO:0003682 [chromatin binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006325 [chromatin organization] GO:0006348 [chromatin silencing at telomere] GO:0006355 [regulation of transcription, DNA-templated] GO:0008168 [methyltransferase activity] GO:0008284 [positive regulation of cell population proliferation] GO:0010718 [positive regulation of epithelial to mesenchymal transition] GO:0016279 [protein-lysine N-methyltransferase activity] GO:0016571 [histone methylation] GO:0016740 [transferase activity] GO:0018024 [histone-lysine N-methyltransferase activity] GO:0031490 [chromatin DNA binding] GO:0032259 [methylation] GO:0035098 [ESC/E(Z) complex] GO:0042054 [histone methyltransferase activity] GO:0042752 [regulation of circadian rhythm] GO:0043406 [positive regulation of MAP kinase activity] GO:0043547 [positive regulation of GTPase activity] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0046976 [histone methyltransferase activity (H3-K27 specific)] GO:0048387 [negative regulation of retinoic acid receptor signaling pathway] GO:0048511 [rhythmic process] GO:0070317 [negative regulation of G0 to G1 transition] GO:0070734 [histone H3-K27 methylation] GO:0071902 [positive regulation of protein serine/threonine kinase activity] GO:1902808 [positive regulation of cell cycle G1/S phase transition] GO:1990841 [promoter-specific chromatin binding]
Enzymes ENZYME proteins Transferases Metabolic proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Missense Mutations Disease related genes FDA approved drug targets Small molecule drugs Human disease related genes Cancers Cancers of haematopoietic and lymphoid tissues Congenital malformations Other congenital malformations Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II] GO:0000781 [chromosome, telomeric region] GO:0000785 [chromatin] GO:0001226 [RNA polymerase II transcription corepressor binding] GO:0003682 [chromatin binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006325 [chromatin organization] GO:0006348 [chromatin silencing at telomere] GO:0006355 [regulation of transcription, DNA-templated] GO:0008168 [methyltransferase activity] GO:0008284 [positive regulation of cell population proliferation] GO:0010718 [positive regulation of epithelial to mesenchymal transition] GO:0016279 [protein-lysine N-methyltransferase activity] GO:0016571 [histone methylation] GO:0016740 [transferase activity] GO:0018024 [histone-lysine N-methyltransferase activity] GO:0031490 [chromatin DNA binding] GO:0032259 [methylation] GO:0035098 [ESC/E(Z) complex] GO:0042054 [histone methyltransferase activity] GO:0042752 [regulation of circadian rhythm] GO:0043406 [positive regulation of MAP kinase activity] GO:0043547 [positive regulation of GTPase activity] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0046976 [histone methyltransferase activity (H3-K27 specific)] GO:0048387 [negative regulation of retinoic acid receptor signaling pathway] GO:0048511 [rhythmic process] GO:0070317 [negative regulation of G0 to G1 transition] GO:0070734 [histone H3-K27 methylation] GO:0071902 [positive regulation of protein serine/threonine kinase activity] GO:1902808 [positive regulation of cell cycle G1/S phase transition] GO:1990841 [promoter-specific chromatin binding]
Enzymes ENZYME proteins Transferases Metabolic proteins Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC Plasma proteins Cancer-related genes Candidate cancer biomarkers Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Missense Mutations Disease related genes FDA approved drug targets Small molecule drugs Human disease related genes Cancers Cancers of haematopoietic and lymphoid tissues Congenital malformations Other congenital malformations Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II] GO:0000781 [chromosome, telomeric region] GO:0000785 [chromatin] GO:0001226 [RNA polymerase II transcription corepressor binding] GO:0003682 [chromatin binding] GO:0003714 [transcription corepressor activity] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0006325 [chromatin organization] GO:0006348 [chromatin silencing at telomere] GO:0006355 [regulation of transcription, DNA-templated] GO:0008168 [methyltransferase activity] GO:0008284 [positive regulation of cell population proliferation] GO:0010718 [positive regulation of epithelial to mesenchymal transition] GO:0016279 [protein-lysine N-methyltransferase activity] GO:0016571 [histone methylation] GO:0016740 [transferase activity] GO:0018024 [histone-lysine N-methyltransferase activity] GO:0031490 [chromatin DNA binding] GO:0032259 [methylation] GO:0035098 [ESC/E(Z) complex] GO:0042054 [histone methyltransferase activity] GO:0042752 [regulation of circadian rhythm] GO:0043406 [positive regulation of MAP kinase activity] GO:0043547 [positive regulation of GTPase activity] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045892 [negative regulation of transcription, DNA-templated] GO:0046976 [histone methyltransferase activity (H3-K27 specific)] GO:0048387 [negative regulation of retinoic acid receptor signaling pathway] GO:0048511 [rhythmic process] GO:0070317 [negative regulation of G0 to G1 transition] GO:0070734 [histone H3-K27 methylation] GO:0071902 [positive regulation of protein serine/threonine kinase activity] GO:1902808 [positive regulation of cell cycle G1/S phase transition] GO:1990841 [promoter-specific chromatin binding]
The Human Protein Atlas project is funded
